Novartis Raises Sales Guidance Until 2028
FRANKFURT – Novartis (NYSE: NVS) raised its medium-term sales guidance on Thursday to 6% annual growth through 2028, driven by […]
Novartis Raises Sales Guidance Until 2028 Read More »
Healthcare
Cinven Gets Green Light from Italy to Sell Minority Stake in Synlab to Labcorp
ROME – Cinven, the private equity firm, secured conditional approval from Italian authorities over its plan to sell a 15%
Cinven Gets Green Light from Italy to Sell Minority Stake in Synlab to Labcorp Read More »
Weight-Loss Drug Coverage Rises Among Largest US Employers, Mercer Survey Finds
NEW YORK – About 44% of U.S. employers with 500 or more employees cover drugs for weight loss in 2024,
Weight-Loss Drug Coverage Rises Among Largest US Employers, Mercer Survey Finds Read More »
Bayer Acquires Rights to Cytokinetics’ Heart Drug in Japan
FRANKFURT – On Tuesday, Bayer struck a collaboration deal with U.S. biotech firm Cytokinetics (NASDAQ: CYTK) to acquire certain rights
Bayer Acquires Rights to Cytokinetics’ Heart Drug in Japan Read More »
Grifols Urges Shareholders to Reject Brookfield Offer Over Valuation Concerns
MADRID – On Tuesday, Grifols (NASDAQ: GRFS) said that Canadian investment fund Brookfield’s potential 6.45 billion euro ($6.8 billion) offer
Grifols Urges Shareholders to Reject Brookfield Offer Over Valuation Concerns Read More »
Medtronic (NYSE: MDT) Lifts Annual Profit Forecast on Strong Demand for Medical Devices
Medtronic (NYSE: MDT) lifted the lower end of its annual profit forecast for a second time on Tuesday, banking on
Medtronic (NYSE: MDT) Lifts Annual Profit Forecast on Strong Demand for Medical Devices Read More »
Spanish Court Opens Investigation Into Gotham City’s Attack on Grifols
MADRID – An investigating magistrate at Spain’s High Court has opened a probe into U.S.-based short seller Gotham City Research’s
Spanish Court Opens Investigation Into Gotham City’s Attack on Grifols Read More »
Healthcare
Ōura Achieves Over $5 Billion Valuation Following Dexcom Funding
On Tuesday, Dexcom (NASDAQ: DXCM), the medical device maker, said it will invest $75 million in Ōura’s latest funding round,
Ōura Achieves Over $5 Billion Valuation Following Dexcom Funding Read More »
Exclusive: Medicaid Fuels US Coverage of Novo, Lilly Weight-Loss Drugs
U.S. government health plans account for the lion’s share of coverage for popular new weight-loss drugs, far beyond the reimbursement
Exclusive: Medicaid Fuels US Coverage of Novo, Lilly Weight-Loss Drugs Read More »
